-
U.S. military research reports that new liquid-coated air filters help trap airborne pathogens
Time of Update: 2023-02-03
ACS Applied Materials & Interfaces, 2022; 14 (45): 50543 Researchers at the University of Maine and the University of Massachusetts Amherst have designed new liquid-coated air filters that can better detect and analyze airborne bacteria and viruses, including those that cause COVID-19, early.
-
Rare target detection of lung cancer, so that every "rare" is "seen
Time of Update: 2023-01-06
At the 5th China International Import Expo (hereinafter referred to as the "Expo"), Roche Diagnostics and Roche Pharmaceutical, together with seven leading domestic genetic testing medical technology
-
Rare target detection of lung cancer, so that every "rare" is "seen
Time of Update: 2023-01-06
At the 5th China International Import Expo (hereinafter referred to as the "Expo"), Roche Diagnostics and Roche Pharmaceutical, together with seven leading domestic genetic testing medical technology
-
mRNA cancer vaccine presses the accelerator button, how is the progress of domestic enterprises catching up with learning
Time of Update: 2023-01-01
"Wang Hai's team of the National Nano Center makes new breakthroughs in tumor nanovaccines", BioWorld, 2022-11-23 In fact, the three major mRNA giants BioNTech, Moderna, CureVac and some domestic mRNA companies, as early as before the development of new crown vaccines, mainly promoted therapeutic cancer vaccines as core projects of their respective mRNA technologies.
-
Acute pancreatitis, the "gold standard" for diagnosis
Time of Update: 2022-09-07
For medical professionals onlyDiagnose and treat the size of the problem, see how the guide says Source: Medical Community Clinical Pharmacy Channel Proofreader: Zang Hengjia Responsible Editor: Tian
-
Thirteen provinces with volume procurement alliance established
Time of Update: 2022-06-14
On April 15, the Henan Provincial Medical Insurance Bureau announced that Henan, Shanxi, Inner Mongolia, Hubei, Hunan, Guangxi, Hainan, Chongqing, Guizhou, Qinghai, Ningxia, Xinjiang, Xinjiang Construction Corps and other thirteen provinces (districts, cities, and Corps) An inter-provincial alliance is formed, and it is planned to carry out centralized and volume-based procurement of the second and fourth batches of drugs that have expired in the state-organized centralized procurement .
-
The price of mixed nucleic acid testing in Shandong has been lowered again: the price standard of 4 yuan will be implemented from the 26th
Time of Update: 2022-05-17
In order to meet the requirements of the new coronavirus pneumonia epidemic prevention and control situation and reduce the burden on the public, on the basis of effectively reducing the price of nuc
-
Jiangxi Province has determined the time for the sixth batch of national procurement bids
Time of Update: 2022-05-13
On May 5, the Jiangxi Provincial Medical Insurance Bureau issued the "Notice on the Implementation of the Selection Results of the Sixth Batch of Nationally Organized Centralized Drug Procurement (Insulin Special)", announcing that from 0:00 on May 25, 2022, medical institutions in the province will begin After the selection result is executed, it is now possible to log in to the recruitment platform to establish a distribution relationship and sign a tripartite agreement .
-
Financing in the pharmaceutical industry is frequent, focusing on cell therapy, ADC, genetic testing and other fields
Time of Update: 2022-04-26
AAV gene therapy new drug research and development company Jinweike recently completed a Pre-A round of financing of tens of millions of yuan .
On March 2, Huayi Lejian, a gene therapy drug research and development company, announced the completion of a series A financing of several hundred million yuan .
-
This circular RNA can inhibit atherosclerosis
Time of Update: 2022-02-24
"After knocking out circEsyt2, the proliferation, migration and phenotypic transition of vascular smooth muscle cells in mice were inhibited, and at the same time, the remodeling of arterial blood vessels in mice was significantly reduced ," said Wu Gengze .
-
AADC gene therapy brings hope to Parkinson's disease patients
Time of Update: 2022-01-09
The researchers published the 36-month safety and clinical outcome of NBIb-1817 (VY-AADC01, an investigational gene therapy for the treatment of Parkinson's disease [not yet FDA approved]) Phase 1b, an open-label, dose-escalation trial .
-
JAMA Neuro: Don't underestimate the MRI report "white matter degeneration", it may be related to the progression of Parkinson's disease
Time of Update: 2021-12-03
In summary, in this cohort study, higher levels of WMH and cerebrovascular disease pathological indexes in the elderly brain are associated with faster Parkinson's disease progression .
-
Finding doctors and medicines is more convenient 20 Beijing hospitals carry out online diagnosis and treatment services
Time of Update: 2021-09-12
(over) Medical Network News, September 7 In order to facilitate patients' medical treatment and combine diagnosis and treatment services under epidemic prevention and control, the Beijing Hospital Management Center said today that the center actively promotes the development of Internet diagnosis and treatment services in municipal hospitals, and carries out online follow-up consultations for some common diseases and chronic diseases.
-
Zhangjiajie issued an emergency notice to strictly regulate the order of medical treatment
Time of Update: 2021-08-14
The notice requires that those who meet the conditions for hospitalization or referral must be admitted to hospitalization or referral, and for non-febrile patients, the first-visit medical institution will arrange vehicle referrals .
-
Hebei Renhe Yikang Pharmaceutical Sodium Valproate Injection Enters the Administrative Approval Stage and Will Be Approved
Time of Update: 2021-04-27
Source: Minet database Medical Network News on March 24 Recently, Hebei Renhe Yikang Pharmaceutical entered the administrative examination and approval stage with the imitation of 3 types of sodium valproate injection, which is expected to be approved in the near future and won the first imitation in China.
